Salmeterol in the treatment of asthma
Curran, M.A.
Australian Family Physician 23(10): 2038
1994
ISSN/ISBN: 0300-8495 PMID: 7818414 Document Number: 434362
Document emailed within 1 workday
Related Documents
Ringbaek, T.J.; Søes-Petersen, U.; Christensen, M.; Iversen, E.T.; Rasmussen, F.V. 1996: Salmeterol improves the control of disease in patients with moderate asthma. a comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily Ugeskrift for Laeger 158(27): 3940-3943Wrońska, J.; Chazan, R.; Mazurek, J.; Droszcz, W. 1998: Treatment with salmeterol and quality of life in patients with asthma Pneumonologia i Alergologia Polska 66(3-4): 193-197
Cayley, W.E. 2009: Should salmeterol be used for long-term asthma control? American Family Physician 79(11): 957
Onadeko, B.O.; Bamidele, E.O.; Ekweani, C.N.; Erabor, G.E. 1994: An open multi-centre study to assess the efficacy of inhaled salmeterol in bronchial asthma in Nigeria African Journal of Medicine and Medical Sciences 23(3): 301-305
Cash, R.; Blonski, J. 2001: In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief? Journal of Family Practice 50(9): 802
Siergiejko, Z. 1998: The effect of salmeterol on specific and non-specific bronchial response in allergic asthma patients Pneumonologia i Alergologia Polska 66(9-10): 440-449
Maneechotesuwan, K.; Assawabhumi, J.; Rattanasaengloet, K.; Suthamsmai, T.; Pipopsuthipaiboon, S.; Udompunturak, S. 2014: Comparison between the effects of generic and original salmeterol/fluticasone combination (SFC) treatment on airway inflammation in stable asthmatic patients Journal of the Medical Association of Thailand 97(Suppl 3): S91-100
2008: Fluticasone/salmeterol: labeling change Prescrire international 17(98): 229
Van Dam, J.G. 1996: Salmeterol no longer banned in Olympic Games Nederlands Tijdschrift Voor Geneeskunde 140(31): 1612
Hu, J.-g.; Jia, W.; Hu, X.-w.; Wang, Y. 2003: Effect of salmeterol on function of bronchi in pneumoconiosis of coal miners Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 21(3): 233-234
Słomka, A. 1997: Evaluation of the effectiveness and safety of salmeterol in children with nocturnal dyspnea Pneumonologia i Alergologia Polska 65(Suppl 1): 44-50
Russell, G.; Williams, D.A.; Weller, P.; Price, J.F. 1995: Salmeterol xinafoate in children on high dose inhaled steroids Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 75(5): 423-428
Kemp, J.P.; Bierman, C.W.; Cocchetto, D.M. 1993: Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring Annals of Allergy 70(4): 316-322
Chazan, R.; Jaworski, A.; Grubek-Jaworska, H.; Droszcz, W. 1995: Effect of 16-week use of salmeterol on ECP levels, pulmonary function tests and bronchial hyperreactivity in patients with chronic obstructive lung disease Polski Tygodnik Lekarski 50(40-44): 48-49; 63
van der Laag, J.; van Aalderen, W.M.; Duiverman, E.J.; van Essen-Zandvliet, E.E.; Nagelkerke, A.F.; van Nierop, J.C. 1991: Asthma in children; consensus by pediatric pulmonologists on long-term treatment. II. Treatment Nederlands Tijdschrift Voor Geneeskunde 135(49): 2319-2323
Stoloff, S.; Samuels, S.; Kerney, D.; Brown, C.P. 2006: Management of chronic obstructive pulmonary disease associated with chronic bronchitis with inhaled fluticasone propionate/salmeterol (ADVAIR DISKUS) 250/50: results of a patient experience trial Medgenmed: Medscape General Medicine 8(1): 86
Ahlbeck, L.; Stridh, B.ör.; Ställberg, B.ör.; Kiotseridis, H.; Janson, C.; Romberg, K. 2018: When and how to step down asthma treatment Lakartidningen 115
Stenius-Aarniala, B. 1998: Current treatment of asthma Duodecim; Laaketieteellinen Aikakauskirja 114(9): 903-911
Hobday, J.D. 1978: Treatment of asthma in children Australian Family Physician 7(2): 185-189
Ciszek, J.; Kazimierczak, A.; Walczak, J. 1976: Kenalog in the treatment of asthma Pneumonologia Polska 44(4): 313-320